MedTrace Logo

The Influence of Tramadol on Platelet Function

NCT05237492 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2024-01-18

No results posted yet for this study

Summary

The aim of this ex-vivo study is to quantify the effect of tramadol on platelet aggregation.

Conditions

  • Drug Toxicity
  • Platelet Dysfunction
  • Clotting Disorder

Interventions

DRUG

Tramadol

Blood samples will be drawn from 15 patients. Tramadol will be added to all this samples in-vitro and its influence on platelets´ function will be measured.

Sponsors & Collaborators

  • Medical University of Graz

    lead OTHER

Principal Investigators

  • Philipp Zoidl, MD · Medical University of Graz

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-01-26
Primary Completion
2023-07-15
Completion
2023-07-15

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05237492 on ClinicalTrials.gov